Formoterol: pharmacology, molecular basis of agonism, and mechanism of long duration of a highly potent and selective beta 2-adrenoceptor agonist bronchodilator

Area of Science:

• Pharmacology
• Respiratory Medicine
• Cell Biology

Background:

• Formoterol is a highly potent and selective beta 2-adrenoceptor agonist.
• It provides rapid onset and prolonged duration of action (>12 hours) for bronchodilation.
• Its properties suggest retention within airway smooth muscle.

Purpose of the Study:

• To investigate the in vitro properties of formoterol as an airway smooth muscle relaxant.
• To explore the mechanisms behind formoterol's prolonged action.
• To evaluate formoterol's inhibitory effects on inflammatory processes in asthma models.

Main Methods:

• In vitro studies on human airway smooth muscle.
• Analysis of formoterol's interaction with the plasmalemma lipid bilayer.
• Experimental testing of formoterol's effects on leukocyte adhesion, emigration, and mediator release.

Main Results:

• Formoterol demonstrated potent and effective relaxation of airway smooth muscle.
• Evidence suggests formoterol is retained in smooth muscle, leading to sustained effects.
• Formoterol potently inhibited inflammatory cell actions and processes relevant to asthma.

Conclusions:

• Formoterol possesses unique pharmacokinetic properties contributing to its long duration of action.
• Formoterol exhibits significant inhibitory effects on key asthma-related inflammatory pathways.
• Further clinical research with histological analysis is warranted to confirm in vivo relevance.